Veeva Systems (VEEV) Stock Rallies As Profit Growth Sharpens Execution Story

Simply Wall St.08-28 07:24

Veeva Systems just put a 15.2% one day surge in front of investors and asked a blunt question: Is the long term thesis on quality, sticky life sciences software finally lining up with the quarterly ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2662343950?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","is_english":true,"pubTime":"2026-08-28 07:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2662343950","market":"sg","top_or_hot":-1,"title":"Veeva Systems (VEEV) Stock Rallies As Profit Growth Sharpens Execution Story","media":"Simply Wall St.","content":"<div>\n<p>Veeva Systems just put a 15.2% one day surge in front of investors and asked a blunt question: Is the long term thesis on quality, sticky life sciences software finally lining up with the quarterly ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-veev/veeva-systems/news/veeva-systems-veev-stock-rallies-as-profit-growth-sharpens-e\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Veeva Systems (VEEV) Stock Rallies As Profit Growth Sharpens Execution Story</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVeeva Systems (VEEV) Stock Rallies As Profit Growth Sharpens Execution Story\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-08-28 07:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-veev/veeva-systems/news/veeva-systems-veev-stock-rallies-as-profit-growth-sharpens-e><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Veeva Systems just put a 15.2% one day surge in front of investors and asked a blunt question: Is the long term thesis on quality, sticky life sciences software finally lining up with the quarterly ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-veev/veeva-systems/news/veeva-systems-veev-stock-rallies-as-profit-growth-sharpens-e\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4534","symbol_name":"瑞士信贷持仓","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-veev/veeva-systems/news/veeva-systems-veev-stock-rallies-as-profit-growth-sharpens-e","article_id":"2662343950","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-veev/veeva-systems/news/veeva-systems-veev-stock-rallies-as-profit-growth-sharpens-e","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2662343950","pubTimestamp":1787873041,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Veeva Systems just put a 15.2% one day surge in front of investors and asked a blunt question: Is the long term thesis on quality, sticky life sciences software finally lining up with the quarterly print? Coming into the release, the stock already carried a rich 45.2x trailing P/E and a reputation for premium pricing on growth.\nThe headline this quarter is earnings power. Fiscal Q2 basic earnings per share landed at US$1.68 on revenue of US$927.96m. Net income excluding extra items reached...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4613":"AI应用软件","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","EKG":"First Trust Nasdaq Lux Digital Health Solutions ETF","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","LU0058720904.USD":"联博国际健康护理基金A","BK4167":"医疗保健技术","VEEV":"Veeva Systems Inc.","LU1989764664.SGD":"CPR Invest - Global Disruptive Opportunities A2 Acc SGD-H","BK4504":"桥水持仓","BK4585":"ETF&股票定投概念","LU1989764748.USD":"东方汇理环球颠覆性机遇A2 Acc","BK4528":"SaaS概念","LGHT":"LANGAR GLOBAL HEALTHTECH ETF","BK4588":"碎股"},"translate_title":"随着利润增长强化执行故事，Veeva Systems (VEEV) 股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LGHT":0.6,"VEEV":1.98,"EKG":0.6},"content_text":"Veeva Systems just put a 15.2% one day surge in front of investors and asked a blunt question: Is the long term thesis on quality, sticky life sciences software finally lining up with the quarterly print? Coming into the release, the stock already carried a rich 45.2x trailing P/E and a reputation for premium pricing on growth. The headline this quarter is earnings power. Fiscal Q2 basic earnings per share landed at US$1.68 on revenue of US$927.96m. Net income excluding extra items reached US$273.43m. The market reaction indicates that investors were willing to pay up for that profit story. Impressed by the earnings power Veeva Systems just demonstrated but hesitant about paying a 45.2x trailing P/E for the stock? Explore our screener of quality stocks that combine premium pricing with strong profitability using the 46 high quality undervalued stocks AdvertisementQ2 2027 Earnings Summary  Revenue (Q2 2027 vs Q2 2026): US$927.96m vs. US$789.08m (up about 17.6%) Net Income Excluding Extra Items (Q2 2027 vs Q2 2026): US$273.43m vs. US$200.31m (up about 36.5%) Basic EPS (Q2 2027 vs Q2 2026): US$1.68 vs. US$1.23 (up about 37.4%) Trailing 12 Month Net Profit Margin (FY to Q2 2027 vs prior year): 29.3% vs. 27.3% (margin expanded by about 2 percentage points)  Prefer clear visuals instead of another wall of earnings tables and footnotes? See Veeva Systems' full financial picture, with a focus on its valuation, in the easy to scan company report for Veeva Systems. NYSE:VEEV Trailing 12-Month Earnings & Revenue History as at Aug 2026 Evaluating Veeva Systems’ Execution Against Its Growth Story The bullish view on Veeva Systems hinges on two things. First, that Vault CRM can replace legacy CRM footprints at large pharma. Second, that AI agents like Falcon and Falcon MLR will become a meaningful fourth pillar alongside software, data and services. This quarter gave tangible milestones for both claims. On CRM, Veeva highlighted global Vault CRM commitments from Eli Lilly and Regeneron and added multiple new top 20 pharma customers, with more than 150 Vault CRM implementations now live. That directly supports the idea that CRM revenue can persist as customers migrate rather than churn. On AI, Falcon and Vault AI are already in early commercialization, and Falcon MLR is live following the Copli deal, targeting up to a 70% cut in manual MLR workload. Paired with an 18% revenue increase and raised FY27 guidance, these developments show the thesis progressing from slideware toward execution. Access the detailed multi year models behind Veeva Systems and see where the consensus starts to break. Reveal what the street is secretly modeling for the next fiscal years in the full analyst estimates for Veeva Systems Veeva Bear Case: CRM and AI Milestones Still Unproven The bearish view on Veeva Systems is that CRM is maturing, AI may not become a durable revenue engine, and revenue quality could lean too heavily on services or acquisitions. This quarter’s record CRM quarter and new global Vault CRM wins at Eli Lilly and Regeneron run directly against fears of immediate CRM erosion. However, bears can point out that Veeva still needs more visible evidence that these migrations convert to long-run share stability across all top pharma. On AI, Falcon, Falcon MLR, and Vault AI are in early commercialization. Management itself calls product readiness and controlled rollout the rate limiter. That means the concern that AI takes longer to matter is not disproved. Revenue mix worries look less supported given strong commercial subscriptions, but the lack of disclosed AI-specific revenue or margin contribution keeps the question of high-quality, AI-driven growth open rather than settled. With Veeva Systems now trading on a 45.2x P/E and investors paying up for profit margins near 30%, the real question is whether the balance sheet supports this premium. Check the full liquidity, cash, and debt profile in the financial health analysis of Veeva Systems stock. Stay Ahead With Veeva Systems Insights If Veeva Systems has your attention after this earnings move and its rich 45.2x P/E, register for free with Simply Wall St and add it to your Watchlist to track price against fair value and watch how the thesis develops. Once you decide to build or adjust a position, keep on top of what matters most with the Portfolio Command Center that filters market noise into focused, portfolio specific alerts. Round out your view by tapping into the Community and seeing how other investors are thinking about Veeva Systems over time. This way you uncover potential catalysts and risks early and give yourself a better chance of staying a step ahead of the market. Seeking Alternatives Beyond Veeva Systems? Fresh opportunities do not wait forever. New themes gather momentum, prices move, and the cleanest entries get caught by early movers. Scan these curated ideas before the crowd and act now.  Track cash rich businesses that can power through shocks and still compound, starting with a curated list of solid balance sheet and fundamentals stocks (50 results) while it remains under the radar for now. Ride structural shifts in mining and electrification before they hit every headline by scanning a focused group of 30 best rare earth metal stocks with rising attention from institutions. Position ahead of potential robotics adoption waves by reviewing a hand picked mix of 38 robotics and automation stocks that could benefit if automation spending accelerates.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.48.0","shortVersion":"4.48.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2662343950","isCrawlerRequest":true}